F. Pandolfi et al., THE ITALIAN QUALITY-CONTROL STUDY FOR EVALUATION OF CD4 CELLS IN CENTERS INVOLVED IN THE TREATMENT OF HIV-1 PATIENTS, Clinical and experimental immunology, 111(3), 1998, pp. 564-573
We report on the experience of establishing a national network for a q
uality control programme in evaluating CD4 cell counts in most Italian
centres involved in the care of patients with HIV disease. The 68 cen
tres were divided according to their geographical location into eight
groups, and twice a year (tests A and B) they received three coded who
le blood samples (two were replicates of the same sample) obtained fro
m two informed HIV+ patients, one with CD4 counts/mm(3) expected to be
<200 and one with values > 300. The medians of the determinations per
formed by the labs involved in each of the eight areas were taken as t
he 'true' values for each sample. Unsatisfactory performances for perc
entage of CD4 cells were identified as a CD4 analysis with residual va
lues greater than or equal to +/- 5% and with deviates greater than or
equal to +/- 2. For absolute numbers of CD4 cells, an unsatisfactory
performance was defined as CD4 counts with residual > +/- 100 CD4 cell
s/mm(3) and with deviates greater than or equal to +/- 2. The residual
value is the CD4 value reported by each lab minus the median value. T
he deviate is the residual divided by the modified interquartile range
(IQR x 0.75). Most of the centres provided reliable results. However,
some labs failed to provide satisfactory results for percentages (6.2
5% of the tested labs for test A and 6.17% for test B) or absolute num
bers (16.25% test A and 12.34% test B). Only 3.7% of the labs gave uns
atisfactory results in both tests. Four of the unsatisfactory results
from the two tests gave an error in absolute numbers > +/- 200 CD4 cel
ls/mm(3). Our data suggest that most Italian labs provide reliable res
ults in evaluating the numbers of CD4 cells in HIV-1(+) samples, but t
he importance of running a quality control programme is highlighted by
our experience with those centres which provide unsatisfactory data w
hich may lead to incorrect classification of the patients or assessmen
t of treatment.